Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
OPRXthis companyOptimizeRx Corp.	$8.87	43.79×	1.77×	2.08×	13.89×	-249.3%	63.3%	11.0%	4.7%	4.0%	5.6%	8.2%	0.2×	0.17×	2.28×	3.04×	0.0%	7	3.67	3	B+
DHDefinitive Healthcare Corp.	$1.16	-2.21×	1.09×	1.27×	-2.22×	-728.9%	75.9%	-8.5%	-57.5%	-49.4%	-3.3%	12.1%	0.61×	-0.06×	-1.82×	1.64×	1.0%	6	-3.14	2	B-
DRUGBright Minds Biosciences Inc.	$23.89	-47.44×	7.08×	0×	-40.98×	-67.6%	0.0%	0.0%	0.0%	-14.9%	-17.0%	-1.5%	0×	6.81×	0×	36.1×	0.0%	1	85.48	2	C+
NAKANakamoto Inc.	$5.68	-1.35×	0.31×	87.61×	-200.13×	-440.3%	-508.8%	-10824.0%	-2867.6%	-10.2%	-27.2%	-14.9%	0.41×	-4.17×	-27.92×	1.04×	0.0%	1	-4.78	2	C+
NRCNRC Health	$26.05	36.1×	30.03×	3.06×	16.38×	-50.4%	56.3%	16.4%	8.4%	82.9%	14.4%	3.7%	5.65×	2.48×	4.74×	0.55×	2.6%	7	3.22	2	C
RXSTRxSight, Inc.	$4.75	-10.97×	1.56×	3.19×	-11.81×	-4900.6%	76.6%	-35.8%	-29.0%	-14.1%	-16.8%	-4.5%	0.04×	0.25×	-1,204.75×	10.95×	0.0%	2	-0.63	2	C+
Peer median	—	-2.21×	1.56×	3.06×	-11.81×	-440.3%	56.3%	-8.5%	-29.0%	-14.1%	-16.8%	-1.5%	0.41×	0.25×	-1.82×	1.64×	0.0%	2	-0.63	2	—